MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGeer, E. G.
Right arrow Articles by McGeer, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGeer, E. G.
Right arrow Articles by McGeer, P. L.
Molecular Interventions 1:22-29 (2001)
© 2001 American Society of Pharmacology and Experimental Therapeutics


Review

Innate Immunity in Alzheimer's Disease

A Model for Local Inflammatory Reactions

Edith G. McGeer and Patrick L. McGeer

Kinsmen Laboratory of Neurological Research, Department of Psychiatry University of British Columbia, Vancouver, BC V6T 1Z3

Correspondence: Address correspondence to EGM. E-mail mcgeer{at}interchange.ubc.ca; fax 604-822-7086.


Amyloid plaques (large extracellular deposits) and neurofibrillary tangles (dense intracellular aggregates) are well-known histological indicators of Alzheimer's disease. Intriguingly, these pathological hallmarks contain all of the major complement proteins that are normally associated with immune activation. The afflicted brain tissue shown here has been stained with antibodies specific for complement proteins.

Over the past fifteen years, evidence has been accumulating that there is a chronic inflammatory reaction in areas of the brain affected by Alzheimer's disease. Chronic inflammation, which arises in reaction to an underlying pathology, represents a threat in its own right, wherever it may occur, and can in fact surpass primary affronts upon tissues. The brain, however, is particularly vulnerable because neurons are generally irreplaceable. In the case of Alzheimer's disease, inflammatory processes thus have the potential for turning a relatively slowly progressing condition into one characterized by rapid neurodegeneration.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Yan, X. Hu, H. Song, K. Yin, R. J. Bateman, J. R. Cirrito, Q. Xiao, F. F. Hsu, J. W. Turk, J. Xu, et al.
Matrix Metalloproteinase-9 Degrades Amyloid-beta Fibrils in Vitro and Compact Plaques in Situ
J. Biol. Chem., August 25, 2006; 281(34): 24566 - 24574.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. K. Stalder, F. Ermini, L. Bondolfi, W. Krenger, G. J. Burbach, T. Deller, J. Coomaraswamy, M. Staufenbiel, R. Landmann, and M. Jucker
Invasion of Hematopoietic Cells into the Brain of Amyloid Precursor Protein Transgenic Mice
J. Neurosci., November 30, 2005; 25(48): 11125 - 11132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.